Amaz­ing Pill Re­verses Mem­ory Loss Used In Italy For 31 Years Goes On Sale Na­tion­wide

Tested and ap­proved by U.S. doc­tors; stud­ies show ac­tive in­gre­di­ents re­verse years of mem­ory loss and work even in se­vere cases of men­tal de­cline; make users sharper and smarter; re­lieve stress; im­prove mem­ory and brain func­tion in days with no harm­ful si

The Star Democrat - - SPORTS - By J.K. Wiley

NMS—A

pill that re­verses years of mem­ory loss and trig­gers en­hance brain func­tion with­out side ef­fects has been used safely in Italy for 31 years. It is now avail­able in the United States with­out a pre­scrip­tion.

The re­mark­able pill con­tains a key in­gre­di­ent, which was irst de­vel­oped by Ital­ian Phar­ma­ceu­ti­cal sci­en­tists in 1987, not only reawaken men­tal func­tion… but also… speed up think­ing and re­ac­tion times in the brain.

It also works to re­store healthy brain cells within the brain’s neu­ral net­work; this is what im­proves mem­ory and learn­ing func­tions.

Now an im­proved ver­sion of this pill is be­ing of­fered in Amer­ica un­der the brand name Prix­elin.

With daily use, the pow­er­ful com­pound in Prix­elin is able to get in­side your brain, and give the brain an in­vig­o­ra­tion en­ergy boost by pro­duc­ing key chem­i­cals that ‘wake up’ healthy brain cells, which im­prove mem­ory, en­hance cog­ni­tive func­tion and think­ing power,” ex­plains Jeremy Wil­liams, Pres­i­dent of the par­ent com­pany be­hind the Prix­elin.

“This is what the clin­i­cal stud­ies have shown and is why so many U.S. doc­tors are now rec­om­mend­ing Prix­elin to pa­tients,” he added. Ex­cit­ing Dis­cov­ery of Mem­ory Loss Re­versed

Prix­elin con­tains an amaz­ing com­pound that has a known abil­ity to im­prove mem­ory and en­hance brain func­tion within days.

The com­pound is not a drug. It is the ac­tive in­gre­di­ent in Prix­elin.

Sci­en­tists be­lieve that Prix­elin’s ac­tive in­gre­di­ent works to block the en­zyme re­spon­si­ble for break­ing down a neu­ro­trans­mit­ter.

The vi­tal neu­ro­trans­mit­ter, called acetyl­choline (or AC), in the brain plays an im­por­tant role for mem­ory, think­ing speed, re­ac­tion times and men­tal ac­tiv­ity.

AC helps our brain cells com­mu­ni­cate. Trans­fer­ring in­for­ma­tion from one area to an­other. With­out it our thoughts be­come “stuck” and we can’t ac­cess in­for­ma­tion and mem­o­ries.

Re­search shows that as we age, the healthy lev­els of AC in our brain be­gins to break down, which causes the brain cells grad­u­ally die.

The re­sults can be de­layed re­ac­tions, slower think­ing, mem­ory loss, and even­tu­ally a com­plete break­down in brain func­tion.

Well, that’s where Prix­elin comes in and why it seems to be so ef­fec­tive.

“I took Prix­elin and felt fab­u­lous. My speech has im­proved, my hands are shak­ing less. I even no­tice that my “se­nior mo­ments” are be­com­ing few and far be­tween,” said Lo­raine Shel­don from Austin, TX.

All this pos­i­tive feed­back makes it easy to un­der­stand why there is so much ex­cite­ment and op­ti­mism sur­round­ing this amaz­ing new mem­ory pill. Clin­i­cal Re­sults That Are Wow­ing The Med­i­cal Com­mu­nity The clin­i­cal stud­ies were con­ducted by top sci­en­tists here in the United States. The re­sults were pub­lished in the pres­ti­gious med­i­cal jour­nal Neu­rol­ogy.

The stud­ies in­cluded both men and women who were suf­fer­ing from age re­lated mem­ory loss. First, they had pa­tients per­form var­i­ous mem­ory tests. Then, they gave half the pa­tients Prix­elin’s ac­tive in­gre­di­ent. They gave the other half a placebo (dummy) pill. After 12 weeks they had the pa­tients do the test again.

The re­sults were as­ton­ish­ing.

The par­tic­i­pants who took the pill as di­rected re­versed their men­tal age by nearly 12 years ac­cord­ing to re­searchers con­duct­ing the stud­ies.

They also saw a huge im­prove­ment in their mem­ory, learn­ing and think­ing abil­ity. They could re­mem­ber the names and faces of peo­ple they never met… ind mis­placed ob­jects quickly… and re­call tele­phone num­bers eas­ily.

An­other study con­ducted in Italy pro­duced sim­i­lar­ity out­stand­ing re­sults, where user ex­pe­ri­enced a 44% im­prove­ment in men­tal func­tion in just 90 days. Noth­ing like it has been seen be­fore.

In fact, the FDA awarded Prix­elin’s ac­tive in­gre­di­ent with a rare “Quali ied Health Claim for both Cog­ni­tive Dys­func­tion and De­men­tia.”

“All I did was take Prix­elin daily like the in­struc­tions said and within days I no­ticed im­prove­ment. Ev­ery­thing seems so much clearer now. It’s like a fog has been lifted from my mind,” said Robert P., from Se­dona, AZ. The Way It Works Is Ex­tra­or­di­nary

Prix­elin is a one-aday pill that’s taken after break­fast. The pill is small. Easy to swal­low. There are no harm­ful side ef­fects. And it does not re­quire a pre­scrip­tion.

Ac­tu­ally, the only ‘side ef­fect’ is that the ac­tive in­gre­di­ents in Prix­elin boost your mood and can even help you sleep bet­ter. Re­searchers be­lieve the Prix­elin’s ac­tive in­gre­di­ent re­duces cor­ti­sol, the brain’s stress hor­mone. Re­sult­ing in less stress, which leads to bet­ter sleep and a more pos­i­tive mood.

Sci­en­tists also be­lieve the key in­gre­di­ent in Prix­elin works to block the en­zyme de­stroys a vi­tal neu­ro­trans­mit­ter called acetyl­choline, or AC.

How im­por­tant is AC? VERY. If you’re able to read this, you can thank your healthy lev­els of AC.

As we age, our AC lev­els go down nat­u­rally. But in peo­ple suf­fer­ing from age-re­lated mem­ory loss, some­thing goes hor­ri­bly wrong, which causes our brain cells grad­u­ally die. If brain cells fail, so does mem­ory.

The re­sults can be lapsed in con­cen­tra­tion, for­get­ful­ness, and men­tal de­cline; and that’s where Prix­elin comes in and why it seems to be so ef­fec­tive.

“I had se­vere mem­ory prob­lems,” said 69 year old David S., of Hen­der­son, NV. “But I can al­ready con­cen­trate and re­mem­ber de­tails bet­ter after only one month with Prix­elin. This pill is eas­ing my fear of de­men­tia,” he added. What Doc­tors Are Say­ing

“Prix­elin is the irst real so­lu­tion to come along for men­tal de­cline that is both side-ef­fect free and sup­ported by clin­i­cal tri­als. If you suf­fer from an age re­lated mem­ory loss, try this prod­uct im­me­di­ately,” said Dr. Peter Gross­man, from Philadel­phia, PA.

“In all my years as med­i­cal doc­tor, there is noth­ing else quite like Prix­elin when it comes to sup­port­ing mem­ory, con­cen­tra­tion and healthy brain func­tion. The prod­uct even re­lieves anx­i­ety and stress with­out side ef­fects,” said Dr. Kim­berly Lang­don, from Colum­bus, OH.

“I rec­om­mend Prix­elin to se­niors who ind it dif icult to re­mem­ber the events, peo­ple and names of their lives. The ev­i­dence shows it is es­pe­cially ef­fec­tive for those who suf­fer from “brain fog” and “se­nior mo­ments”,” said Dr. Jenny Reategui, from Los An­ge­les, CA. Spe­cial Op­por­tu­nity To Get Prix­elin

This is the of icial na­tion­wide re­lease of Prix­elin in the United States. And so, the com­pany is of­fer­ing a spe­cial dis­count sup­ply to any mem­ory loss suf­fers who calls within the next 48-hours.

A Re­gional Or­der Hot­line has been set up for lo­cal read­ers to call. This gives every­one an equal chance to try Prix­elin.

Start­ing at 7:00 AM to­day, the or­der hot­line will be open for 48-hours. All you have to do is call TOLL­FREE 1-800-591-3977 and pro­vide the op­er­a­tor with the spe­cial dis­count BB762. ap­proval code: The com­pany will do the rest. Im­por­tant:

Due to Prix­elin’s re­cent me­dia ex­po­sure, phone lines are of­ten busy. If you call and do not im­me­di­ately get through, please be pa­tient and call back. Those who miss the 48-hour dead­line may have to pay full price for Prix­elin.

MEM­ORY LOSS RE­VERSED: Doc­tors are now rec­om­mend­ing new Prix­elin to se­niors suf­fer­ing from sym­toms of mem­ory loss and men­tal de­cline. Ini­tial users in U.S. re­port im­prove­ments in mem­ory, speech, think­ing and learn­ing func­tions with­out side ef­fects.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.